top border
top border
Featured Program
Treatment of Advanced Head & Neck Squamous Cell Carcinoma
Ezra Cohen, MD; Robert Ferris, MD, PhD, FACS; and Jared Weiss, MD, provide a comprehensive overview of diagnosis and treatment of advanced head and neck squamous cell carcinoma (HNSCC), including multidisciplinary care and emerging evidence surrounding novel therapies. Treatment approaches to HPV-positive and HPV-negative tumors are explored.

Although most patients with differentiated thyroid cancer have an excellent prognosis, a subset of these patients will develop a more aggressive, refractory phenotype. This OncLive Peer Exchange moderated by R. Michael Tuttle, MD, focuses the latest information about how to use available therapies and the path forward to a more personalized approach for patients. The expert panel of endocrinologists and oncologists includes Marcia S. Brose, MD, PhD; Naifa Busaidy, MD, FACP, FACE; Eric J. Sherman, MD; and Francis Paul Worden, MD.
View Now
Immunotherapy and Oncology

Anti-Angiogenic Therapy in Lung and GI Cancers

Anti-Angiogenic Therapy in Lung and GI Cancers
Mark Socinski, MD, moderates this OncLive Peer Exchange panel discussion on modern use of anti-angiogenic therapy. The experts in gastrointestinal and lung cancers include Johanna C. Bendell, MD; Edward Garon, MD; Roy Herbst, MD; Yelena Y. Janjigian, MD; and Manish Shah, MD.
View Now
Vincent T. DeVita Jr MD
In The Death of Cancer, written by Vincent T. DeVita Jr, MD, a pioneering oncologist reveals, after 50 years on the front lines of medicine, why the war on cancer is winnable, and how to get there.
Publication Bottom Border
Border Publication